SCHEMBL1075504

SCHEMBL1075504

CN(C(=O)O)c1ccc(N2CCOCC2)c(CCc2cccc(N)c2)c1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.39
KMT2A Q03164 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
NPC1 O15118 1/20 0.39
ALDH1A1 P00352 5/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C19 P33261 1/20 0.38
AOC3 Q16853 4/20 0.38
GAA P10253 2/20 0.38
KDM4E B2RXH2 1/20 0.38
HPGD P15428 1/20 0.38
NAPEPLD Q6IQ20 1/20 0.38
MAPT P10636 1/20 0.38
TSHR P16473 1/20 0.37
MAOA P21397 2/20 0.36
MAOB P27338 2/20 0.36
SIGMAR1 Q99720 1/20 0.36
PIK3CA P42336 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1025252 0.80 ALDH1A1 (0.39) MEN1KMT2ASMN1; SMN2NPC1ALDH1A1
SCHEMBL1023637 0.76 KMT2A (0.46) MEN1KMT2ASMN1; SMN2NPC1ALDH1A1
SCHEMBL1075283 0.76 PDE2A (0.39) SMN1; SMN2NPC1GAAKDM4EHPGD
SCHEMBL1027667 0.76 ALDH1A1 (0.44) MEN1KMT2ASMN1; SMN2NPC1ALDH1A1
SCHEMBL13670051 0.75 MAPT (0.48) MEN1KMT2ASMN1; SMN2ALDH1A1GAA
SCHEMBL17536983 0.72 SMN1; SMN2 (0.50) MEN1KMT2ASMN1; SMN2NPC1ALDH1A1
SCHEMBL13623214 0.71 AKT1 (0.49) MEN1KMT2ASMN1; SMN2NPC1ALDH1A1
SCHEMBL425066 0.70 AKR1C3 (0.50) MEN1KMT2ASMN1; SMN2NPC1ALDH1A1
SCHEMBL13622523 0.70 AKT1 (0.41) MEN1KMT2ASMN1; SMN2NPC1ALDH1A1
SCHEMBL428323 0.69 ALDH1A1 (0.42) MEN1KMT2ASMN1; SMN2NPC1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2274288-A2 MACROCYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS Incyte Corporation (US) 2011-01-19 EP disclosed
WO-2009132202-A2 MACROCYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS INCYTE CORPORATION (US) 2009-10-29 WO disclosed